Sign Out
Pregnancy: There are no adequate and well-controlled studies in pregnant women. Epoetin alfa should be used in pregnancy only if the potential benefit outweighs the potential risk to the fetus. The use of Epoetin alfa is not recommended in pregnant surgical patients participating in an autologous blood predonation programme.
Lactation: It is not known whether exogenous Epoetin alfa is excreted in human milk. Epoetin alfa should be used with caution in nursing women. A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with Epoetin alfa should be made taking into account the benefit of breast-feeding to the child and the benefit of Epoetin alfa therapy to the woman. The use of Epoetin alfa is not recommended in lactating surgical patients participating in an autologous blood predonation programme.
